CurrentCardio
Get Weekly

Topic · page 14 of 28

Coronary disease & ACS

Acute and chronic coronary syndromes, MI, INOCA/ANOCA, revascularisation strategy, antithrombotic therapy after ACS/PCI, chest-pain diagnostics

Briefs 521–560 of 1,104 placed here, newest publication first

Briefs in Coronary disease & ACS

Newest publication first

  1. JACC Cardiovasc Interv

    Balloon Lithotripsy Added to Conventional Preparation Before Stent Implantation in Severely Calcified Coronary Lesions

    Randomised controlled trial

  2. Europace

    Electrophysiological characteristics of Purkinje potentials and the conduction system in premature ventricular contractions triggering ventricular fibrillation after myocardial infarction

    Cohort study

  3. J Am Coll Cardiol

    Cardiovascular Risk Across Myocardial Injury and Infarction Categories Using the Universal Definition: An Individual Patient-Level Data Meta-Analysis

    Meta-analysis

  4. JACC Cardiovasc Interv

    Anatomical vs Physiological Lesion Characteristics in Prediction of Acute Coronary Syndrome

    Case-control study

  5. JACC Cardiovasc Interv

    Fractional Flow Reserve to Guide Revascularization in Patients With Coronary Artery Disease Undergoing TAVR

    Secondary analysis

  6. JACC Cardiovasc Interv

    Long-Term and Temporal Relationships Between Post-Stent Fractional Flow Reserve and Clinical Outcomes

    Cohort study

  7. JACC Cardiovasc Imaging

    Stress Cardiac Magnetic Resonance Ischemia Burden and Cardiovascular Events: Post-Hoc Analysis From the ISCHEMIA Trial

    Secondary analysis

  8. Eur J Prev Cardiol

    ESC quality indicators for post-myocardial infarction care: transition and chronic coronary syndrome phases

    Guideline or statement

  9. JACC Cardiovasc Imaging

    Prognostic Value of AI-Based Quantitative Coronary CTA vs Human Reader-Based Visual Assessment: Results From the CONFIRM2 Registry

    Cohort study

  10. Circulation

    Oxidized Phospholipids, Lipoprotein(a), and Cardiovascular Outcomes After Acute Coronary Syndrome

    Secondary analysis

  11. J Am Coll Cardiol

    Early vs Late Staged PCI After Subintimal Tracking and Re-Entry for Chronic Total Occlusions: A Randomized Trial

    Randomised controlled trial

  12. Eur Heart J

    Frailty and long-term outcomes in younger patients with acute myocardial infarction

    Cohort study

  13. JAMA

    Long-Term Continuous Monitoring of New-Onset Atrial Fibrillation After Coronary Artery Bypass Grafting

    Cohort study

  14. Eur J Prev Cardiol

    Association of body mass index on 10-year outcomes in patients treated with percutaneous coronary intervention and drug-eluting stents (the DECADE cooperation)

    Meta-analysis

  15. Eur J Prev Cardiol

    Severe mental illness, chest pain, and emergency response

    Cohort study

  16. Circulation

    Evidence-Based Practices in the Cardiac Catheterization Laboratory: Invasive Epicardial Coronary Physiologic Assessment: A Scientific Statement From the American Heart Association

    Guideline or statement

  17. JACC Cardiovasc Interv

    Rationales Behind Physiology-Guided Revascularization: Diagnostic Impact of Quantitative Flow Ratio in the FAVOR III China Trial

    Secondary analysis

  18. Eur Heart J

    Optical coherence tomography-guided stent optimization for complex coronary lesions: the OCCUPI trial

    Secondary analysis

  19. Circulation

    Coronary Artery Revascularization in the Older Adult Population: A Scientific Statement From the American Heart Association

    Guideline or statement

  20. J Am Coll Cardiol

    Potent P2Y12 Inhibitor Monotherapy vs DAPT After PCI in Patients With and Without STEMI: The NEO-MINDSET Substudy

    Secondary analysis

  21. JACC Cardiovasc Interv

    15-Year Cardiovascular Risk in Patients With Angina Without Obstructive Coronary Arteries

    Cohort study

  22. Eur J Prev Cardiol

    Anxiety and depression and secondary prevention of coronary heart disease in 14 countries across six WHO regions: the INTERASPIRE study

    Cross-sectional study

  23. Eur J Prev Cardiol

    Outcomes after coronary angiography in individuals with elevated lipoprotein(a)

    Cohort study

  24. Eur J Prev Cardiol

    Polygenic prediction of coronary heart disease among 130 000 Mexican adults

    Cohort study

  25. Eur J Prev Cardiol

    Type D personality, unhealthy behaviours, and 2-year outcomes after acute coronary syndrome: a cohort study

    Cohort study

  26. Eur Heart J

    Endotypes of angina with non-obstructive coronary arteries: a prospective multicentre study

    Cohort study

  27. JAMA

    Fractional Flow Reserve–Guided Complete vs Culprit-Only Revascularization in Non–ST-Elevation Myocardial Infarction and Multivessel Disease: The SLIM Randomized Clinical Trial

    Randomised controlled trial

  28. J Am Coll Cardiol

    Safety of Using Risk Stratification Along With High-Sensitivity Cardiac Troponin in the Emergency Department: A Secondary Analysis

    Secondary analysis

  29. Nat Med

    Endotyping-informed therapy for patients with chest pain and no obstructive coronary artery disease: a randomized trial

    Randomised controlled trial

  30. Circulation

    State of the Art: Evaluation and Medical Management of Nonobstructive Coronary Artery Disease in Patients With Chest Pain: A Scientific Statement From the American Heart Association

    Guideline or statement

  31. Lancet

    Complete versus culprit lesion-only revascularisation for acute myocardial infarction (Complete Revascularisation Trialists' Collaboration): an individual patient data meta-analysis of randomised trials

    Meta-analysis

  32. N Engl J Med

    Beta-Blockers after Myocardial Infarction with Normal Ejection Fraction

    Meta-analysis

  33. Circulation

    Triple Versus Dual Lipid-Lowering Therapy in Acute Coronary Syndrome: The ES-BempedACS Randomized Clinical Trial

    Randomised controlled trial

  34. Eur J Prev Cardiol

    Secondary prevention education initiated in hospital for people with coronary heart disease: a systematic review and meta-analysis

    Meta-analysis

  35. Eur J Prev Cardiol

    Therapies leading to coronary atherosclerosis plaque regression: a scientific statement of the European Association of Preventive Cardiology, the European Association of Cardiovascular Imaging of the ESC, the ESC Working Group on Atherosclerosis and Vascular Biology, and the ESC Working Group on Cardiovascular Pharmacotherapy Part 2—drugs’ specific effect on atherosclerosis

    Guideline or statement

  36. Eur J Prev Cardiol

    Minimal extra-cardiac atherosclerosis present in young people with sudden cardiac death due to coronary artery disease

    Cohort study

  37. JAMA Cardiol

    Physiology-Guided Complete Revascularization in Older Patients With Myocardial Infarction: Three-Year Outcomes of a Randomized Clinical Trial

    Randomised controlled trial

  38. JAMA Cardiol

    Subclinical Coronary Atherosclerosis and Retinal Optical Coherence Tomography Angiography

    Cross-sectional study

  39. JACC Cardiovasc Interv

    AI-Enabled ECG Analysis Improves Diagnostic Accuracy and Reduces False STEMI Activations: A Multicenter U.S. Registry

    Diagnostic or prognostic study

  40. J Am Coll Cardiol

    PCI of Native Coronary Artery vs Saphenous Vein Graft After Prior Bypass Surgery: A Multicenter, Randomized Trial

    Randomised controlled trial

All 1,104 Briefs in ExploreShowing Briefs 521–560 of 1,104, newest first